Skip to main content Help with accessibility Skip to main navigation

Liraglutide

Indication

As an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial Body Mass Index (BMI) of • ≥ 30 kg/m² (obese), or • ≥ 27 kg/m² to < 30 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as dysglycaemia (pre-diabetes or type 2 diabetes mellitus), hypertension, dyslipidaemia or obstructive sleep apnoea.
Black

Brand:

Saxenda ®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Endocrine system

Background

NOT recommended for use by the NHS in Lancashire and South Cumbria.
There is insufficient evidence of long-term safety, sustained weight loss and cost effectiveness in patients using saxenda.

Recommendation

LSCMMG Recommendation:

Black

Reason for decision:

Not recommended for prescribing on the NHS in Lancashire & South Cumbria

Supporting documents:

Decisions of Lancashire local decision making groups

Black
Black
Black
Black
Black
Black
Black
Black
What do the colours mean?

Last Updated: 09 - Dec - 2019